Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example. (Record no. 25726653)

MARC details
000 -LEADER
fixed length control field 00754 a2200205 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517080902.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201602s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2056-5933
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/rmdopen-2015-000154
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lai, Zhihong
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160212
245 00 - TITLE STATEMENT
Title Key design considerations on comparative clinical efficacy studies for biosimilars: adalimumab as an example.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. RMD open
Date of publication, distribution, etc. 2016
300 ## - PHYSICAL DESCRIPTION
Extent e000154 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Review
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name La Noce, Anna
773 0# - HOST ITEM ENTRY
Title RMD open
Related parts vol. 2
-- no. 1
-- p. e000154
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1136/rmdopen-2015-000154">https://doi.org/10.1136/rmdopen-2015-000154</a>
Public note Available from publisher's website

No items available.